There are data suggesting that SS patients have lower retinoic acid concentrations and higher IL-17 expression levels in their serum compared to healthy controls, and NOD mice treated with retinoic acid showed reduced numbers of α4β7-negative Th17 cells and lower levels of IL-17 in vivo (43). Here, IL17A is linked to synovial sarcoma.